Topiramate extended-release capsules are indicated for: Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 6 years of age and older; adjunctive therapy for the treatment of partial-onset, primary generalized tonicclonic seizures, or seizures associated with Lennox-Gastaut syndrome (LGS) in patients 6 years of age and older; Preventive treatment of migraine in patients 12 years of age and older (1.3)